Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms-Reference-Cited by-同舟云学术

Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms

Published:2015-02-18 Issue:4 Volume:13 Page:631-642
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Espasandin Y. R.¹,Glembotsky A. C.¹,Grodzielski M.¹,Lev P. R.¹,Goette N. P.¹,Molinas F. C.¹,Marta R. F.¹,Heller P. G.¹

Affiliation:

1. Departamento de Hematología Investigación; Instituto de Investigaciones Médicas Alfredo Lanari; Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); Buenos Aires Argentina

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Agencia Nacional de Promoción Científica y Tecnológica

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12850/fullpdf

Reference31 articles.

1. Anagrelide: a new drug for treating thrombocytosis;Silverstein;N Engl J Med,1988

2. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group;Angrelide Study Group;Am J Med,1992